5_Ghostwriting - Ross


Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
trials conducted by the company that were eventually published for which data were available (or would soon be available), including Merck protocols 010, 029, 033, 034, 035, 040, 041, 044, 045, 050, 058, 068, 072, 085, 088 (VIGOR), 090, 097, 098, 102 (ADVANTAGE), 103, 120, 121, 901, and 902. 22 For each of these study pro- tocols, a Merck employee is desig- nated within the report as the author of the first draft of the manuscript. Ex- amining the published articles, the first author is an external, academically af- filiated investigator for 16 of 20 ar- ticles (some protocols were combined into single articles), 15,16,18,23-35 with the exception of protocols 010, 029, 058, and 072, 36-39 3 of which had external, academically affiliated investigators listed as authors, but not in the first au- thorship position. Among these 16 ar- ticles, all had 2 or more external, aca- demically affiliated investigators who were attributed authorship (median, 4.5; range, 2-10) and these authors oc- cupied 77% of the first, second, and
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 10/10/2010 for the course ENG 000121 taught by Professor Mcgrand during the Spring '10 term at Cornell.

Ask a homework question - tutors are online